Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study-Reference-Cited by-同舟云学术

Simultaneous determination of fixed dose combination of nebivolol and valsartan in human plasma by liquid chromatographic-tandem mass spectrometry and its application to pharmacokinetic study

Published:2007-10 Issue:1-2 Volume:858 Page:143-150
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Selvan P. Senthamil,Gowda K. Veeran,Mandal U.,Solomon W.D. Sam,Pal T.K.

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference12 articles.

1. The Merck Index,2001

2. Nebivolol

3. The Merck Index,2001

4. Valsartan in the treatment of hypertension

5. Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Method Development and Validation of Valsartan by Using Stability-Indicating RP-HPLC Method;Advances in Pharmacology and Pharmacy;2024-10

2. Mapping Advantages and Challenges in Analytical Development for Fixed Dose Combination Products, a Review;Journal of Pharmaceutical Sciences;2024-08

3. Simple and Economical Uv-Spectrophotometric Method for Simultaneous Estimation of Chlorthalidone and Nebivolol in Combined Tablet Dosage Form: An Alternative Approach to the HPLC Method;Journal of Applied Spectroscopy;2024-01

4. Nanosized ethosomal dispersions for enhanced transdermal delivery of nebivolol using intradermal/transfollicular sustained reservoir: in vitro evaluation, confocal laser scanning microscopy, and in vivo pharmacokinetic studies;Pharmaceutical Development and Technology;2023-12-11

5. Clinical pharmacokinetics of nebivolol: a systematic review;Drug Metabolism Reviews;2023-10-02